Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Osthole
Cat. No.:
OB0225LY-0169
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Product Overview
Description:
Osthole is a potential histamine H1 receptor inhibitor.
Synonym:
Osthol; NSC 31868; Ostol; 484-12-8
CAS No.:
484-12-8
Formula:
C15H16O3
Formula Weight:
244.29
Specification
Relative Density:
1.126 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Osthole can be used to stimulate osteoblast proliferation and differentiation.
Library Information
Targets:
Histamine receptor
Receptors:
H1 receptor
Pathways:
Neuronal signaling; Apoptosis; GPCR/G protein; Microbiology/Virology; Immunology/Inflammation
Plate Number:
AOCL-3
Plate Location:
b2
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
55 mg/mL; 225.14 mM
Water Max Solubility:
<1 mg/mL (insoluble or slightly soluble)
Ethanol Max Solubility:
46 mg/mL; 188.3 mM
